BioReliance Selects Cyto Study Manager to Streamline Genetic Toxicology Services
Instem Software Chosen to Support Acquisition, Management & Reporting of Genetic Toxicology Data
CONSHOHOCKEN, PA - (BUSINESS WIRE) - October 30, 2015 - - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that BioReliance® has purchased the Cyto Study Manager (CSM) software system to support genetic toxicology processes at its research site in Rockville, Maryland.
Developed by Perceptive Instruments, which now operates as part of Instem, Cyto Study Manager integrates data acquisition, auditing, reporting and study management into a single system that greatly improves efficiencies, while ensuring data integrity during genetic toxicology investigations.
BioReliance, a provider of testing and manufacturing services to pharmaceutical and biopharmaceutical companies worldwide, is the largest supplier of safety testing services to the rapidly growing biologics sector and a long-time user of Instem technologies such as the Provantis preclinical software suite.
Key Facts
- Long-standing client expands use of Instem technologies with purchase of Cyto Study Manager software system
- Integrated study setup, data collection and reporting will speed up processes and improve client response times
- Cyto Study Manager provides BioReliance GLP and FDA 21 CFR part 11 compliance for electronic signatures, comprehensive auditing, archiving and historical control features
Gregor Grant, Senior Vice President, Instem, commented “It is extremely pleasing to see continued demand for our Cyto Study Manager software system and we are delighted to welcome a leading organization such as BioReliance to our growing user community.”
Perceptive Instruments (Perceptive), now operating as part of Instem, develops, manufactures and supplies image analysis and data processing solutions that are primarily focused on the areas of genetic toxicology, microbiology and immunology. Perceptive solutions are deployed in over 50 countries at leading universities and research institutes and are supporting various government programs such as those at the National Center for Toxicological Research, a Food & Drug Administration division. Perceptive products also serve small and medium-sized companies along with many of today’s multinational organizations, including many of the leading global pharmaceutical companies.
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
Meeting clients at the intersection of investment & return™.
Press Contacts:
Instem
Gary Mitchell (US HQ)
gary.mitchell@instem.com
Tel: 610-941-0990
Julie Jones (UK HQ)
julie.jones@instem.com
Tel: +44 (0) 1785 825600